Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
admission, Alexander, annum, appeal, Apr, Apria, barring, Baxter, capacity, Carolina, Chairwoman, Chapel, Cheryl, Circuit, CLC, coaching, Cohen, convertible, cybersecurity, cytotoxic, Dan, datedDecember, Davidson, de, decade, delegate, deliver, DelMar, dismissed, distinction, Doctor, drafting, effort, electrical, eleven, enzalutamide, enzyme, eric, Feb, geopolitical, Hill, HTGC, Huntingdon, hydrochloride, inadequacy, inappropriate, interruption, invited, JAMA, LADR, LADRTM, latitude, launch, lender, lessee, Letter, liaison, lift, literature, loan, Medivation, mentoring, metastic, methodology, Morphotek, Morton, move, moved, Niedermayer, Niedermeyer, olaratumab, Olivia, Oncol, ontuxizumab, Opdivo, Oppenheimer, outsourced, paragraph, payload, petition, preliminarily, prime, proof, properly, prostate, provisional, purportedly, refiling, remedial, remediate, remediation, remedy, residual, resumed, revoke, rose, sand, Sep, Stipulation, supplier, telecommunication, theft, theretofore, thereunder, Tokai, traditional, unchanged, unusual, variable, virtually, vivo, vulnerable, Wainwright, Ware, Welsh, worth, wrongdoing, Xtandi
Filing tables
Filing exhibits
- 10-K Annual report
- 4.5 Common Stock Purchase Warrant Issued to Alexander Capital, L.P.
- 10.11 Form of Non-qualified Stock Option Grant to Non-employee Directors
- 10.12 Form of Non-qualified Stock Option Grant for Executive Officers
- 10.13 Form of Non-qualified Stock Option for Grants to S. Kriegsman and DR. D. Levitt
- 10.14 Amendment No. 1 to Stock Option Agreements of DR. Daniel Levitt, Dated Dec. 31, 2015
- 10.15 Amendment No. 1 to Stock Option Agreements (2000 Plan) of Steven. Kriegsman, Dated March 8, 2016
- 10.16 Amendment No. 1 to Stock Option Agreements (2008 Plan) of Steven. Kriegsman, Dated March 8, 2016
- 10.26 DR. Daniel Levitt Employment Agreement Dated December 31, 2015
- 10.27 Benjamin Levin Employment Agreement Dated December 31, 2015
- 10.28 Scott Wieland Employment Agreement Dated December 31, 2015
- 10.29 John Caloz Employment Agreement Dated December 31, 2015
- 10.30 Olivia Ware Employment Agreement Dated January 11, 2016
- 32 Letter Agreement with Alexander Capital LLP Dated Feb. 9, 2016
- 10.36 Steven Kriegsman Third Amendment to 4TH Amended and Restated Employment Agreement Dated March 8, 2016
- 23.1 Consent of Bdo USA, LLP
- 31.1 Certification of Chief Executive Officer, Pursuant to 15 U.s.c. Section 7241
- 31.2 Certification of Chief Financial Officer, Pursuant to 15 U.s.c. Section 7241
- 32.1 Certification of Chief Executive Officer, Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of Chief Financial Officer, Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
LADX similar filings
Filing view
External links
Exhibit 32.2
Certification of Chief Financial Officer
Pursuant to 18 U.S.C. 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of CytRx Corporation (the "Company") hereby certifies that:
(i) the accompanying Annual Report on Form 10-K of the Company for the year ended December 31, 2014 (the "Report") fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
CYTRX CORPORATION | |||
Date: March 11, 2016 | By: | /s/ JOHN Y. CALOZ | |
John Y. Caloz | |||
Chief Financial Officer | |||
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 (Section 906), or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to CytRx Corporation and will be retained by CytRx Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission as an Exhibit to the Form 10-K and shall not be considered filed as part of the Form 10-K.